NGX Bio Raises $3 Million to Fund Growth of Its DNA Sequencing Marketplace
16 August 2017 - 1:00AM
NGX Bio, Inc., (www.NGXbio.com) the premier marketplace for online
DNA sequencing services, announced it has closed a $3 million
funding round. The round was led by 180 Degree Capital Corp.
(NASDAQ:TURN) and included Third Kind Venture Capital, Lateral
Capital, the Band of Angels and the Berkeley Angel Network, as well
as other investors.
NGX Bio was founded in 2014 to provide
streamlined, on-line access to next-generation sequencing services
for clients seeking high quality, rapid and cost-effective
sequencing of both human and non-human samples globally.
Demand for sequencing services is growing exponentially. NGX
Bio’s platform matches the sequencing needs of customers with
providers who have available sequencing capacity. Customers
are able to purchase a wide range of sequencing services for their
samples using NGX Bio’s online ordering tools. NGX Bio offers
these services through numerous and deep relationships with its
extensive network of sequencing service providers. The
ability to offer virtually unlimited sequencing capacity, to finish
projects rapidly, and to always stay at the cutting edge of
fast-evolving sequencing technologies distinguishes NGX Bio from
its competitors and from internal corporate, academic or government
sequencing resources.
“We appreciate the support from our investors to
fund the next stage of the growth of our business,” said Denis
Kourakin, President and Chief Executive Officer of NGX Bio.
“Our platform makes completion of sequencing projects simpler and
more affordable for all clients and allows them to scale without
the need for capital investment. This funding will allow us
to continue our relentless focus on delivering high-quality, rapid
and cost-effective sequencing solutions for our customers."
About NGX Bio:
NGX Bio is a San Francisco-based company
providing streamlined, on-line access to next generation sequencing
services for clients seeking high quality, rapid and cost-effective
sequencing solutions globally. Founded in 2014 by two
professors of Stanford University, NGX Bio offers virtually
unlimited sequencing capacity to its customers through its
partnerships with numerous sequencing providers.
Contact:
Denis Kourakin
Phone: +1 (415) 464 6379
e-mail: denis@ngxbio.com
180 Degree Capital (NASDAQ:TURN)
Historical Stock Chart
From Apr 2024 to May 2024
180 Degree Capital (NASDAQ:TURN)
Historical Stock Chart
From May 2023 to May 2024